RecruitingNot Applicable

Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics

France60 participantsStarted 2023-03-08

Plain-language summary

In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease. Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).

Who can participate

Age range

70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female ≥ 70 ans * Person have good locomotion, move independently * Personne agree to participate Groupe 1 : 17≤MMSE≤24 (GRECO) Diagnosis of neurodegenerative diseases (major neurocognitive disorders: Alzheimer, mixed dementia, lobar frontotemporal degeneration, vascular dementia). Groupe 2 : MMSE ≥ à 25 (GRECO) Without neurodegenerative disease Exclusion Criteria: * Person with legal protective measures * Person deprived of liberty * Mental retardation or MMSE≤ 16 * Understanding verbal disorders * Visual major disturbances * Person with disease causing increased fatigue * Person with psychiatric pathology excepted anxiety disorder or depression with mild episodes. * Person not covered by French national health insurance

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

To compare performance obtaining to overall score remind ecological MAI between older persons with neurocognitive disorders (groupe 1) and older persons without neurocognitive disorders (groupe 2).

Timeframe: day 1

Trial details

NCT IDNCT05668598

SponsorCentre Hospitalier de Lens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-03-08

Contact for this trial

Brunhilde CANESSON

03.21.69.16.36 bcanesson@ch-lens.fr

View on ClinicalTrials.gov More Memory Disorders trials